Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.17M Buy
96,747
+45,100
+87% +$1.26M 0.03% 1038
2026
Q1
$1.89M Buy
51,647
+35,284
+216% +$1.39M 0.03% 877
2025
Q4
$746K Buy
+16,363
New +$729K 0.02% 1257
2025
Q3
Sell
-51,125
Closed -$1.59M 2529
2025
Q2
$1.59M Buy
+51,125
New +$1.38M 0.07% 427
2024
Q3
Sell
-12,916
Closed -$331K 2062
2024
Q2
$331K Buy
+12,916
New +$290K 0.03% 895
2023
Q2
Sell
-21,064
Closed -$276K 1395
2023
Q1
$276K Buy
+21,064
New +$269K 0.06% 719

Other funds holding AORT

XTX Topco's AORT Position: Q2 2026 in Review

XTX Topco increased its Artivion (AORT) stake by 87% in Q2 2026, buying an estimated $1.26M and bringing the position to 96,747 shares worth $2.17M. The position accounts for 0.03% of the portfolio, ranked #1038.

XTX Topco first reported a position in AORT in Q1 2023 and has held it in 6 quarters since. 206 funds tracked by Wall St. Rank hold AORT as of Q2 2026.

  • XTX Topco held 96,747 shares of Artivion worth $2.17M as of Q2 2026.
  • XTX Topco bought 45,100 Artivion shares in Q2 2026, an estimated $1.26M.
  • Artivion made up 0.03% of XTX Topco's portfolio in Q2 2026, its #1038 holding.
  • XTX Topco first reported a position in Artivion in Q1 2023 and has held it in 6 quarters since.
  • 206 funds tracked by Wall St. Rank held Artivion as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.